Summary

  • CONX completed its acquisition of approximately 75% of HC2 Broadcasting on 1 September. INNOVATE retained approximately 25%, and CONX appoints two of the three directors.
  • The US$105 million bridge loan was extinguished through the merger. CONX also committed up to US$75 million of equity, but only an undisclosed portion was funded at closing.
  • INNOVATE has 18 months after closing to buy interests back from CONX through a US$45 million option pool based on a US$300 million formula value.
  • EchoStar has until 29 May 2028 to exercise once for up to 80.1% of HC2. An exercise notice starts a valuation and transfer process; it does not itself prove a new owner or a completed payment.

A closing normally turns possibility into ownership. CONX's purchase of HC2 Broadcasting did that on 1 September—but only for the present tense.

The closing Form 8-K records an approximately 75% interest for CONX Broadcast and approximately 25% for the former parent, INNOVATE. HC2 then converted into a limited liability company. Its three-member board gives CONX two appointments and INNOVATE one. That is a current majority in both capital and ordinary board appointments.

It is not a terminal ownership map. Two option agreements survived the close. One can move up to 15% back toward INNOVATE. The other can move up to 80.1% to EchoStar. The useful question is therefore not simply who bought HC2, but which document proves control at each date.

The 75% interest was not a conventional cash receipt

CONX's stake was built through a refinancing-and-merger sequence. In May, its merger subsidiary funded a US$105 million bridge loan to HC2. The signing Form 8-K says the money retired 8.50% and 11.45% notes and repurchased certain equity held by noteholders. The loan carried 8% payment-in-kind interest and, if the merger failed to occur, a one-year maturity and a minimum cash-return mechanism.

At closing, the bridge and capitalised interest were extinguished through the merger. CONX also committed to fund up to US$75 million of equity after closing. The INNOVATE closing announcement says only a portion was funded at closing; it does not disclose that portion. The rest remains payable subject to possible reductions for adjustments, expenses and indemnification obligations.

Those facts reject a tempting but false addition. US$105 million of extinguished debt plus a US$75 million commitment does not equal US$180 million of cash paid to INNOVATE. INNOVATE says it received no cash proceeds from this closing unless the separate EchoStar option is exercised. Debt conversion, money injected into HC2 and sale proceeds to the former parent are different ledgers.

INNOVATE can move the first boundary

INNOVATE's retained stake comes with an 18-month purchase option. Under the option agreement, it may make one or more purchases from CONX using an aggregate option pool of US$45 million. Each exercise amount is divided by a US$300 million value and applied to the fully diluted interest count at that exercise date.

At the formula base, US$45 million equals 15%. But the agreement warns that the aggregate percentage can be more or less than 15% of the starting fully diluted count because that denominator may change between exercises. Certain proceeds from INNOVATE asset sales must also be applied to the option, subject to the agreement's exceptions and working-capital mechanics. Calling the instrument an option does not mean every future purchase is entirely discretionary.

Until an exercise notice, money and transferred units appear, the approximately 25% retained interest remains the relevant public state. The option is a right and, in defined circumstances, a use-of-proceeds rule—not current ownership.

EchoStar owns a route, not the stations

The larger control switch belongs to EchoStar. Its letter agreement permits one exercise notice for up to 80.1% of HC2 on a fully diluted basis. The deadline is 29 May 2028, two years after signing; the September close did not restart the clock.

After the merger, an exercise would ordinarily require EchoStar to buy all HC2 interests then held by CONX and enough from INNOVATE to reach the cap. Starting from an unchanged 75/25 split, that would mean 75 percentage points from CONX and 5.1 from INNOVATE. This is only an illustration. Post-closing adjustments, dilution and an INNOVATE exercise can change the quantities before any EchoStar transaction.

INNOVATE receives a short decision window around an EchoStar exercise. It can use its own option, or require EchoStar to buy all rather than only part of INNOVATE's remaining HC2 interest. Thus a single EchoStar notice can open more than one seller path.

The price is not fixed at US$300 million. EchoStar, CONX and INNOVATE first try to agree HC2's fair market value. If they fail, a nationally recognised investment bank applies methods including discounted cash flow and comparable-company analysis. The result cannot fall below the merger-implied equity value; a US$300 million floor applies after specified INNOVATE-option events.

Even then, notice is not closing. EchoStar may decline to consummate after the valuation firm reports if that value is not reasonably acceptable, provided its notice was delivered in good faith. It must then pay the valuation firm's fees. That contractual exit makes four records essential: notice, valuation, payment and transferred ownership.

A large footprint sits behind a small revenue line

INNOVATE says HC2 and its subsidiaries operate more than 260 broadcast television stations and distribute more than 50 networks across more than 40 states. These are issuer-reported scale measures, not an independent count of every live licence, station or network.

The latest pre-close operating figures are more modest. INNOVATE's June-quarter Form 10-Q reports Spectrum revenue of US$5.4 million for the quarter, down from US$5.7 million, and US$10.7 million for the first half, down from US$11.9 million. It attributes the decline mainly to network and market terminations, partly offset by launches.

At 30 June, the held-for-sale Spectrum balance sheet contained US$175.0 million of assets and US$140.8 million of liabilities. Those figures predate the close. They are neither a purchase-price allocation nor a post-close fair-value statement. The next useful evidence will be HC2's opening balance sheet under CONX, the remaining equity funding, a fully diluted ownership schedule and operating results on a consistent perimeter.

CONX controls HC2 today. EchoStar holds a potential path to control it later. Treating both statements as true is not equivocation; it is the only way to keep a completed acquisition separate from an unexercised option.

Sources